FDA Adverse Event Injury Summary report: N

STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON

MDR report key: 8805200 · Received July 18, 2019

Report

Report Number
3009784280-2019-00530
Event Type
Injury
Date Received
July 18, 2019
Date of Event
January 9, 2019
Report Date
July 1, 2019
Manufacturer
SPECTRANETICS
Product Code
ONU
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

EVENT: CORRECTED APPROXIMATE MONTHS FROM 11 MONTHS TO 13 MONTHS.

Description of Event or Problem · 0

APPROXIMATELY 13 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED RESTENOSIS.

Additional Manufacturer Narrative · 1

THE PATIENT REQUIRED REVASCULARIZATION OF THE TARGET LESION. THIS IS BEING REPORTED AS A FOLLOW-UP TO THE CLINICAL STUDY. CROSS REFERENCE MFR REPORT NUMBERS: 3009784280-2019-00529, 3009784280-2019-00531, 3009784280-2019-00532. REPORT SOURCE: FOREIGN- (B)(6)/ STUDY NAME: (B)(6)- PATIENT ID # (B)(6). PMA NUMBER IS NOT APPLICABLE. THE DEVICE IS A NON-COMMERCIAL PRODUCT WITH A CE MARK THAT WAS USED AS PART OF A CLINICAL STUDY. DURING THE INDEX PROCEDURE, THE PRODUCT WORKED AS INTENDED. THE DEVICE WAS DISCARDED, THUS NO PRODUCT EVALUATION WAS PERFORMED. PER THE IFU, RESTENOSIS IS LISTED AS A POTENTIAL COMPLICATIONS/ADVERSE EVENTS.

Description of Event or Problem · 1

IT WAS REPORTED THROUGH A CLINICAL STUDY THAT DURING THE INDEX PROCEDURE ON (B)(6) 2017, FOUR STELLAREX CATHETERS WERE USED TO TREAT THE TARGET LESION OF THE RIGHT PROXIMAL, MID, AND DISTAL SFA AND POPLITEAL, P1 AND P3. APPROXIMATELY 11 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED RESTENOSIS. A SUCCESSFUL REVASCULARIZATION OF THE TARGET LESION WAS PERFORMED ON (B)(6) 2019. THE PHYSICIAN INDICATED THIS IS NOT RELATED TO THE STUDY DEVICE OR PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
596449 STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON DCB PTA CATHETER ONU SPECTRANETICS A35SX050120135 FFX17D21A

Patients

Seq Age Sex Outcome Treatment
1 74 YR Hospitalization| R